| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute promyelocytic leukemia mutated to radioresistance suppressed monocyte lineage differentiation by phorbol 12-myristate 13-acetate
|
Monzen, Satoru
|
|
2013
|
37 |
9 |
p. 1162-1169
8 p.
|
artikel
|
| 2 |
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death
|
Altman, Jessica K.
|
|
2013
|
37 |
9 |
p. 1004-1009
6 p.
|
artikel
|
| 3 |
A fraction rich in phenyl propanoids from L. divaricata aqueous extract is capable of inducing apoptosis, in relation to H2O2 modulation, on a murine lymphoma cell line
|
Martino, Renzo
|
|
2013
|
37 |
9 |
p. 1137-1143
7 p.
|
artikel
|
| 4 |
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies
|
Graux, Carlos
|
|
2013
|
37 |
9 |
p. 1100-1106
7 p.
|
artikel
|
| 5 |
CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21)
|
Iriyama, Noriyoshi
|
|
2013
|
37 |
9 |
p. 1021-1026
6 p.
|
artikel
|
| 6 |
Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation
|
Wei, Shuning
|
|
2013
|
37 |
9 |
p. 1010-1015
6 p.
|
artikel
|
| 7 |
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation
|
Zhu, Xiaoli
|
|
2013
|
37 |
9 |
p. 1046-1051
6 p.
|
artikel
|
| 8 |
Combination of YM155, a survivin suppressant with a STAT3 inhibitor: A new strategy to treat diffuse large B-cell lymphoma
|
Kaneko, Naoki
|
|
2013
|
37 |
9 |
p. 1156-1161
6 p.
|
artikel
|
| 9 |
CXCR4 is a good survival prognostic indicator in multiple myeloma patients
|
Bao, Li
|
|
2013
|
37 |
9 |
p. 1083-1088
6 p.
|
artikel
|
| 10 |
Development of a novel treatment for leukemia directed at tumor-associated mRNA splicing
|
Daines, Dayle A.
|
|
2013
|
37 |
9 |
p. 1125-1131
7 p.
|
artikel
|
| 11 |
Early T-cell precursor leukemia/lymphoma in adults and children
|
Allen, Ashleigh
|
|
2013
|
37 |
9 |
p. 1027-1034
8 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2013
|
37 |
9 |
p. CO2-
1 p.
|
artikel
|
| 13 |
Evaluation of TNF superfamily molecules in multiple myeloma patients: Correlation with biological and clinical features
|
Lemancewicz, Dorota
|
|
2013
|
37 |
9 |
p. 1089-1093
5 p.
|
artikel
|
| 14 |
Expression levels of IL-27 and IL-17 in multiple myeloma patients: A higher ratio of IL-27:IL-17 in bone marrow was associated with a superior progression-free survival
|
Song, Xiao-Ning
|
|
2013
|
37 |
9 |
p. 1094-1099
6 p.
|
artikel
|
| 15 |
Fludarabine: A review of the clear benefits and potential harms
|
Lukenbill, Joshua
|
|
2013
|
37 |
9 |
p. 986-994
9 p.
|
artikel
|
| 16 |
Follicular lymphoma with leukemic phase at diagnosis: A series of seven cases and review of the literature
|
Beltran, Brady E.
|
|
2013
|
37 |
9 |
p. 1116-1119
4 p.
|
artikel
|
| 17 |
Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes
|
Sherman, Alexander E.
|
|
2013
|
37 |
9 |
p. 998-1003
6 p.
|
artikel
|
| 18 |
Growth of xenotransplanted leukemia cells is influenced by diet nutrients and is attenuated with 2-deoxyglucose
|
Tsunekawa-Imai, Norikazu
|
|
2013
|
37 |
9 |
p. 1132-1136
5 p.
|
artikel
|
| 19 |
Hepatitis B infection increases the risk of non-Hodgkin lymphoma: A meta-analysis of observational studies
|
Dalia, Samir
|
|
2013
|
37 |
9 |
p. 1107-1115
9 p.
|
artikel
|
| 20 |
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha
|
Stauffer Larsen, Thomas
|
|
2013
|
37 |
9 |
p. 1041-1045
5 p.
|
artikel
|
| 21 |
[No title]
|
Burack, W. Richard
|
|
2013
|
37 |
9 |
p. 1184-
1 p.
|
artikel
|
| 22 |
Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
|
Attar, Eyal C.
|
|
2013
|
37 |
9 |
p. 1016-1020
5 p.
|
artikel
|
| 23 |
Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma
|
Chen, Yingtai
|
|
2013
|
37 |
9 |
p. 1120-1124
5 p.
|
artikel
|
| 24 |
Publisher's note
|
|
|
2013
|
37 |
9 |
p. 985-
1 p.
|
artikel
|
| 25 |
RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway
|
Cao, Jiang
|
|
2013
|
37 |
9 |
p. 1170-1177
8 p.
|
artikel
|
| 26 |
Sequence of novel agents in multiple myeloma: An instrumental variable analysis
|
Baz, Rachid
|
|
2013
|
37 |
9 |
p. 1077-1082
6 p.
|
artikel
|
| 27 |
The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation
|
Hashmi, Shahrukh
|
|
2013
|
37 |
9 |
p. 1052-1056
5 p.
|
artikel
|
| 28 |
The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network
|
Tan, Daryl
|
|
2013
|
37 |
9 |
p. 1070-1076
7 p.
|
artikel
|
| 29 |
The role of 18F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia
|
Gafter-Gvili, Anat
|
|
2013
|
37 |
9 |
p. 1057-1062
6 p.
|
artikel
|
| 30 |
The role of intracellular pathways in the proliferation of human K562 cells mediated by muscarinic receptors
|
Aydın, Banu
|
|
2013
|
37 |
9 |
p. 1144-1149
6 p.
|
artikel
|
| 31 |
The role of TC-PTP (PTPN2) in modulating sensitivity to imatinib and interferon-α in CML cell line, KT-1 cells
|
Nishiyama-Fujita, Yuriko
|
|
2013
|
37 |
9 |
p. 1150-1155
6 p.
|
artikel
|
| 32 |
“To switch or not to switch: That is the question”—More than 10% of ratio @ 3 months: How to treat chronic myeloid leukemia patients with this response?
|
Breccia, Massimo
|
|
2013
|
37 |
9 |
p. 995-997
3 p.
|
artikel
|
| 33 |
Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma
|
Casulo, Carla
|
|
2013
|
37 |
9 |
p. 1178-1183
6 p.
|
artikel
|
| 34 |
Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABLIS or log reduction from the baseline level?
|
Qin, Ya-Zhen
|
|
2013
|
37 |
9 |
p. 1035-1040
6 p.
|
artikel
|
| 35 |
10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group
|
Minarik, Jiri
|
|
2013
|
37 |
9 |
p. 1063-1069
7 p.
|
artikel
|
Tijdschrift beschrijving